Dr. Agarwal’s Health Care Limited announced strong unaudited consolidated financial results for H1 FY2026. Total income increased by 20.2% YoY to INR 1,007 Crores, while EBITDA grew by 24.9% YoY to INR 285 Crores. The company’s network includes 258 facilities across 10 countries. The momentum in the expansion plans, resilient demand, and the second half of the year typically delivering stronger performance is expected to drive future growth.
H1 FY2026 Financial Highlights
Dr. Agarwal’s Health Care Limited reported significant growth in its unaudited consolidated financial results for the first half of fiscal year 2026:
- Total Income: Soared by 20.2% YoY to INR 1,007 Crores.
- EBITDA: Increased by 24.9% YoY to INR 285 Crores.
- Profit After Tax (PAT): Grew by 88.4% YoY to INR 75 Crores.
Q2 FY2026 Performance
The company also highlighted its performance for Q2 FY2026:
- Total Income: INR 507 Crores, a growth of 18.2% YoY.
- Revenue from Operations: INR 499 Cr, up by 19.7% YoY, with INR 445 Cr from India (19.8% YoY growth).
- Surgeries: 78,399 surgeries performed, a growth of 13.3% YoY.
- EBITDA: INR 144 Cr, a growth of 21.2% YoY, with EBITDA margins of 28.4%.
- Profit after Tax: INR 36 Cr, a growth of 71.0% YoY, with profit after tax margins of 7.2%.
Network and Operational Growth
As of September 30, 2025, the company’s network comprised 258 facilities, after adding 11 new centers during the quarter. During the first half of fiscal year 2026, the network expanded by a total of 24 facilities. The company served over 14 lakh patients and performed over 157,000 surgeries.
Management Commentary
According to Dr. Adil Agarwal, CEO, the company crossed the INR 1,000 Cr Total Income milestone for the first time. While topline growth moderated due to festivities and heavy rainfall, margins strengthened, demonstrating continued focus on profitability and operational excellence.
Source: BSE
